Patents by Inventor Patrick Thayer

Patrick Thayer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240157629
    Abstract: Bioprinters use biological inks (i.e. bioinks) to produce biomaterials such as cell cultures (including 3D cell cultures), living tissues, and organs. Bioprinters as described by the present invention include those capable of performing high-throughput industrial scale assays, applications, and development while maintaining precision.
    Type: Application
    Filed: March 14, 2022
    Publication date: May 16, 2024
    Inventors: Hector Martinez, Patrick Thayer, Erik Gatenholm, Holger Eickhoff
  • Patent number: 11931966
    Abstract: Systems and methods for optical assessments of bioink printability are described. The systems and methods include the use of hardware, software and optical targets to aid in the evaluation of bioink printability. The optical targets are developed and fabricated from 3D printable materials determined to be “nozzle fidelic” and/or materials that possess well characterized thermosensitivity. The optical targets make it possible to rapidly compare and evaluate bioink printability and can be easily customized and tailored for specific applications.
    Type: Grant
    Filed: January 25, 2019
    Date of Patent: March 19, 2024
    Assignee: CELLINK BIOPRINTING AB
    Inventors: Patrick Thayer, Hany Abushall, Hector Martinez, Erik Gatenholm
  • Patent number: 11186736
    Abstract: The present invention relates to a double network bioink that is customizable and tailorable in terms of mechanical characteristics, diffusivity, and biological functionality that is printable at room temperature and cytocompatible. Double network bioinks of the present invention can be utilized as a standard for comparison and evaluation of bioinks and during calibration and/or are suited for the education field as a “blank slate” bioink that can be utilized to convey different scientific concepts. Specific bioinks included comprise: one or more biocompatible or non-biocompatible thickener; one or more polyethylene glycol based crosslinkable network; one or more photoinitiator; and/or optionally, one or more additives to impart desired and/or different characteristics to the bioink. In embodiments the thickener and polyethylene glycol based crosslinkable network form a structure comprising two interpenetrating networks.
    Type: Grant
    Filed: October 10, 2019
    Date of Patent: November 30, 2021
    Assignee: CELLINK AB
    Inventors: Hector Martinez, Patrick Thayer, Erik Gatenholm
  • Publication number: 20210179871
    Abstract: The present invention relates to a double network bioink that is customizable and tailorable in terms of mechanical characteristics, diffusivity, and biological functionality that is printable at room temperature and cytocompatible. Double network bioinks of the present invention can be utilized as a standard for comparison and evaluation of bioinks and during calibration and/or are suited for the education field as a “blank slate” bioink that can be utilized to convey different scientific concepts. Specific bioinks included comprise: one or more biocompatible or non-biocompatible thickener; one or more polyethylene glycol based crosslinkable network; one or more photoinitiator; and/or optionally, one or more additives to impart desired and/or different characteristics to the bioink. In embodiments the thickener and polyethylene glycol based crosslinkable network form a structure comprising two interpenetrating networks.
    Type: Application
    Filed: October 10, 2019
    Publication date: June 17, 2021
    Inventors: Hector Martinez, Patrick Thayer, Erik Gatenholm
  • Publication number: 20210031456
    Abstract: Systems and methods for optical assessments of bioink printability are described. The systems and methods include the use of hardware, software and optical targets to aid in the evaluation of bioink printability. The optical targets are developed and fabricated from 3D printable materials determined to be “nozzle fidelic” and/or materials that possess well characterized thermosensitivity. The optical targets make it possible to rapidly compare and evaluate bioink printability and can be easily customized and tailored for specific applications.
    Type: Application
    Filed: January 25, 2019
    Publication date: February 4, 2021
    Inventors: Patrick Thayer, Hany Abushall, Hector Martinez, Erik Gatenholm
  • Publication number: 20210001009
    Abstract: Bioink compositions comprising a biomaterial (mammalian, plant based, synthetically derived, or microbially derived) such as a hydrogel and a microbial-, fungal-, or plant-produced polysaccharide, with or without cells, for use in the 3D bioprinting of human tissues and scaffolds are described. The bioink compositions have excellent printability and improved cell function, viability and engraftment. Furthermore, the bioink compositions can be supplemented through the additional of auxiliary proteins and other molecules such as growth factors including extracellular matrix components, Laminins, super affinity growth factors and morphogens. The bioink compositions can be used under physiological conditions related to 3D bioprinting parameters which are cytocompatible (e.g. temperature, printing pressure, nozzle size, bioink gelation process).
    Type: Application
    Filed: October 25, 2019
    Publication date: January 7, 2021
    Inventors: Adel Itedale Namro Redwan, Patrick Thayer, Hector Martinez, Erik Gatenholm